These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22174294)

  • 1. Linking PharmGKB to phenotype studies and animal models of disease for drug repurposing.
    Hoehndorf R; Oellrich A; Rebholz-Schuhmann D; Schofield PN; Gkoutos GV
    Pac Symp Biocomput; 2012; ():388-99. PubMed ID: 22174294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extraction of pharmacogenetic and pharmacogenomic relations--a case study using PharmGKB.
    Buyko E; Beisswanger E; Hahn U
    Pac Symp Biocomput; 2012; ():376-87. PubMed ID: 22174293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and bioinformatics: PharmGKB.
    Thorn CF; Klein TE; Altman RB
    Pharmacogenomics; 2010 Apr; 11(4):501-5. PubMed ID: 20350130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2005; 311():179-91. PubMed ID: 16100408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards prediction and prioritization of disease genes by the modularity of human phenome-genome assembled network.
    Jiang JQ; Dress AW; Chen M
    J Integr Bioinform; 2010 Nov; 7(2):. PubMed ID: 21098881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Database systems for knowledge-based discovery.
    Jagarlapudi SA; Kishan KV
    Methods Mol Biol; 2009; 575():159-72. PubMed ID: 19727614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Factorization-Based Prediction of Novel Drug Indications by Integrating Genomic Space.
    Dai W; Liu X; Gao Y; Chen L; Song J; Chen D; Gao K; Jiang Y; Yang Y; Chen J; Lu P
    Comput Math Methods Med; 2015; 2015():275045. PubMed ID: 26078775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary pharmacogenetic assays in view of the PharmGKB database.
    Tilleman L; Weymaere J; Heindryckx B; Deforce D; Nieuwerburgh FV
    Pharmacogenomics; 2019 Mar; 20(4):261-272. PubMed ID: 30883266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PhenomeNET: a whole-phenome approach to disease gene discovery.
    Hoehndorf R; Schofield PN; Gkoutos GV
    Nucleic Acids Res; 2011 Oct; 39(18):e119. PubMed ID: 21737429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation.
    Huang YF; Yeh HY; Soo VW
    BMC Med Genomics; 2013; 6 Suppl 3(Suppl 3):S4. PubMed ID: 24565337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontology-based knowledge discovery in pharmacogenomics.
    Coulet A; Smaïl-Tabbone M; Napoli A; Devignes MD
    Adv Exp Med Biol; 2011; 696():357-66. PubMed ID: 21431576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation mining experiments in the pharmacogenomics domain.
    Rinaldi F; Schneider G; Clematide S
    J Biomed Inform; 2012 Oct; 45(5):851-61. PubMed ID: 22580177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive systems biology approach to broad-spectrum, host-directed drug target discovery in infectious diseases.
    Felciano RM; Bavari S; Richards DR; Billaud JN; Warren T; Panchal R; Krämer A
    Pac Symp Biocomput; 2013; ():17-28. PubMed ID: 23424108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network and pathway analysis of compound-protein interactions.
    Brennan RJ; Nikolskya T; Bureeva S
    Methods Mol Biol; 2009; 575():225-47. PubMed ID: 19727618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining heterogenous data for prediction of disease related and pharmacogenes.
    Funk CS; Hunter LE; Cohen KB
    Pac Symp Biocomput; 2014; ():328-39. PubMed ID: 24297559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGxMine: Text mining for curation of PharmGKB.
    Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
    Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying aberrant pathways through integrated analysis of knowledge in pharmacogenomics.
    Hoehndorf R; Dumontier M; Gkoutos GV
    Bioinformatics; 2012 Aug; 28(16):2169-75. PubMed ID: 22711793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.